Control of T cell viability

Annual Review of Immunology

Volumn 22, Issue , 2004, Pages 765-787

  Marrack, Philippa ^a,b   Kappler, John ^a,b  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Activated; Death; Memory; Na ve; Survival

Indexed keywords

BIM PROTEIN; FAS ANTIGEN; INTERFERON; INTERLEUKIN 1; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; PROTEIN BAK; PROTEIN BCL 2; PROTEIN BCL XL; STAT1 PROTEIN; STAT3 PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN PRESENTING CELL; CELL COUNT; CELL DEATH; CELL DIVISION; CELL INTERACTION; CELL SURVIVAL; CELL TYPE; CELL VIABILITY; CYTOKINE PRODUCTION; HUMAN; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; MACROPHAGE; MAJOR HISTOCOMPATIBILITY COMPLEX; MEMORY CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN FAMILY; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ANIMALS; CELL DEATH; CELL SURVIVAL; HUMANS; IMMUNOLOGIC MEMORY; LYMPHOCYTE ACTIVATION; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 2542482697     PISSN: 07320582     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.immunol.22.012703.104554     Document Type: Review

References (157)

1. Murali-Krishna K, Altman JD, Suresh M, Sourdive DJ, Zajac AJ, et al. 1998. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity 8:177-87
2. Vella A, Teague TK, Ihle J, Kappler J, Marrack P. 1997. Interleukin 4 (IL-4) or IL-7 prevents the death of resting T cells: stat6 is probably not required for the effect of IL-4. J. Exp. Med. 186:325-30
3. Hassan J, Reen DJ. 1998. IL-7 promotes the survival and maturation but not differentiation of human post-thymic CD4+ T cells. Eur. J. Immunol. 28:3057-65
4. Soares MV, Borthwick NJ, Maini MK, Janossy G, Salmon M, Akbar AN. 1998. IL-7-dependent extrathymic expansion of CD45RA+ T cells enables preservation of a naive repertoire. J. Immunol. 161:5909-17
5. Webb LM, Foxwell BM, Feldmann M. 1999. Putative role for interleukin-7 in the maintenance of the recirculating naive CD4+ T-cell pool. Immunology 98:400-5
6. Rathmell JC, Farkash EA, Gao W, Thompson CB. 2001. IL-7 enhances the survival and maintains the size of naive T cells. J. Immunol. 167:6869-76
7. Teague TK, Schaefer BC, Hildeman D, Bender J, Mitchell T, et al. 2000. Activation-induced inhibition of interleukin 6-mediated T cell survival and signal transducer and activator of transcription 1 signaling. J. Exp. Med. 191:915-26
8. Ben-Sasson SZ, Makedonski K, Hu-Li J, Paul WE. 2000. Survival and cytokine polarization of naive CD4(+) T cells in vitro is largely dependent on exogenous cytokines. Eur. J. Immunol. 30:1308-17
9. Zhou YW, Aritake S, Tri Endharti A, Wu J, Hayakawa A, et al. 2003. Murine lymph node-derived stromal cells effectively support survival but induce no activation/proliferation of peripheral resting T cells in vitro. Immunology 109:496-503
10. Kopf M, Baumann H, Freer G, Freudenberg M, Lamers M, et al. 1994. Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 368:339-42
11. Magram J, Connaughton SE, Warrier RR, Carvajal DM, Wu CY, et al. 1996. IL-12-deficient mice are defective in IFN gamma production and type 1 cytokine responses. Immunity 4:471-81
12. Kuhn R, Rajewsky K, Muller W. 1991. Generation and analysis of interleukin-4 deficient mice. Science 254:707-10
13. DiSanto JP, Guy-Grand D, Fisher A, Tarakhovsky A. 1996. Critical role for the common cytokine receptor gamma chain in intrathymic and peripheral T cell selection. J. Exp. Med. 183:1111-18
14. Thomis DC, Berg LJ. 1997. Peripheral expression of Jak3 is required to maintain T lymphocyte function. J. Exp. Med. 185:197-206
15. Nakajima H, Shores EW, Noguchi M, Leonard WJ. 1997. The common cytokine receptor gamma chain plays an essential role in regulating lymphoid homeostasis. J. Exp. Med. 185:189-95
16. Peschon JJ, Morissey PJ, Grabstein KH, Ramsdell FJ, Maraskovsky E, et al. 1994. Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice. J. Exp. Med. 180:1955-60
17. von Freeden-Jeffry U, Vieira P, Lucian LA, McNeil T, Burdach SE, Murray R. 1995. Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine. J. Exp. Med. 181:1519-26
18. Boursalian TE, Bottomly K. 1999. Survival of naive CD4 T cells: roles of restricting versus selecting MHC class n and cytokine milieu. J. Immunol. 162:3795-801
19. Vivien L, Benoist C, Mathis D. 2001. T lymphocytes need IL-7 but not IL-4 or IL-6 to survive in vivo. Int. Immunol. 13:763-68
20. Schluns KS, Kieper WC, Jameson SC, Lefrancois L. 2000. Interleukin-7 mediates the homeostasis of naive and memory CD8 T cells in vivo. Nat. Immunol. 1:426-32
21. Tan JT, Dudl E, LeRoy E, Murray R, Sprent J, et al. 2001. IL-7 is critical for homeostatic proliferation and survival of naive T cells. Proc. Natl. Acad. Sci. USA 98:8732-37
22. Barner M, Mohrs M, Brombacher F, Kopf M. 1998. Differences between IL-4R alpha-deficient and IL-4-deficient mice reveal a role for IL-13 in the regulation of Th2 responses. Curr. Biol. 8:669-72
23. Webb LM, Foxwell BM, Feldmann M. 1997. Interleukin-7 activates human naive CD4+ cells and primes for interleukin-4 production. Eur. J. Immunol. 27:633-40
24. Vuillier F, Scott-Algara D, Dighiero G. 1991. Extensive analysis of lymphocyte subsets in normal subjects by three-color immunofluorescence. Nouv. Rev. Fr. Hematol. 33:31-38
25. Kanegane H, Tosato G. 1996. Activation of naive and memory T cells by interleukin-15. Blood 88:230-35
26. Akbar AN, Borthwick NJ, Wickremasinghe RG, Panayoitidis P, Pilling D, et al. 1996. Interleukin-2 receptor common gamma-chain signaling cytokines regulate activated T cell apoptosis in response to growth factor withdrawal: selective induction of anti-apoptotic (bcl-2, bcl-xL) but not pro-apoptotic (bax, bcl-xS) gene expression. Eur. J. Immunol. 26:294-99
27. Mueller DL, Seiffert S, Fang W, Behrens TW. 1996. Differential regulation of bcl-2 and bcl-x by CD3, CD28, and the IL-2 receptor in cloned CD4+ helper T cells. A model for the long-term survival of memory cells. J. Immunol. 156:1764-71
28. Takeda S, Rodewald HR, Arakawa H, Bluethmann H, Shimizu T. 1996. MHC class II molecules are not required for survival of newly generated CD4+ T cells, but affect their long-term life span. Immunity 5:217-28
29. Tanchot C, Lemonnier FA, Perarnau B, Freitas AA, Rocha B. 1997. Differential requirements for survival and proliferation of CD8 naive or memory T cells. Science 276:2057-62
30. Kirberg J, Berns A, von Boehmer H. 1997. Peripheral T cell survival requires continual ligation of the T cell receptor to major histocompatibility complex-encoded molecules. J. Exp. Med. 186:1269-75
31. Beutner U, MacDonald HR. 1998. TCR-MHC class n interaction is required for peripheral expansion of CD4 cells in a T cell-deficient host. Int. Immunol. 10:305-10
32. Ernst B, Lee DS, Chang JM, Sprent J, Surh CD. 1999. The peptide ligands mediating positive selection in the thymus control T cell survival and homeostatic proliferation in the periphery. Immunity 11:173-81
33. Kieper WC, Jameson SC. 1999. Homeostatic expansion and phenotypic conversion of naive T cells in response to self peptide/MHC ligands. Proc. Natl. Acad. Sci. USA 96:13306-11
34. Bender J, Mitchell T, Kappler J, Marrack P. 1999. CD4+ T cell division in irradiated mice requires peptides distinct from those responsible for thymic selection. J. Exp. Med. 190:367-74
35. Goldrath AW, Bevan MJ. 1999. Low-affinity ligands for the TCR drive proliferation of mature CD8+ T cells in lymphopenic hosts. Immunity 11:183-90
36. Nesic D, Vukmanovic S. 1998. MHC class I is required for peripheral accumulation of CD8+ thymic emigrants. J. Immunol. 160:3705-12
37. Brocker T. 1999. The role of dendritic cells in T cell selection and survival. J. Leukoc. Biol. 66:331-35
38. Muranski P, Chmielowski B, Ignatowicz L. 2000. Mature CD4+ T cells perceive a positively selecting class II MHC/peptide complex in the periphery. J. Immunol. 164:3087-94
39. Clarke SR, Rudensky AY. 2000. Survival and homeostatic proliferation of naive peripheral CD4+ T cells in the absence of self peptide: MHC complexes. J. Immunol. 165:2458-64
40. Dorfman JR, Stefanova I, Yasutomo K, Germain RN. 2000. CD4+ T cell survival is not directly linked to self-MHC-induced TCR signaling. Nat. Immunol. 1:329-35
41. Dorfman JR, Germain RN. 2002. MHC-dependent survival of naive T cells? A complicated answer to a simple question. Microb. Infect. 4:547-54
42. Rodriguez-Barbosa JI, Zhao Y, Zhao G, Ezquerra A, Sykes M. 2002. Murine CD4 T cells selected in a highly disparate xenogeneic porcine thymus graft do not show rapid decay in the absence of selecting MHC in the periphery. J. Immunol. 169:6697-710
43. Seddon B, Legname G, Tomlinson P, Zamoyska R. 2000. Long-term survival but impaired homeostatic proliferation of naive T cells in the absence of p561ck. Science 290:127-31
44. Konig R, Shen X, Maroto R, Denning TL. 2002. The role of CD4 in regulating homeostasis of T helper cells. Immunol. Res. 25:115-30
45. Shen X, Konig R. 2001. Post-thymic selection of peripheral CD4+ T-lymphocytes on class II major histocompatibility antigen-bearing cells. Cell Mol. Biol. (Noisy-le-grand) 47:87-96
46. Seddon B, Zamoyska R. 2002. TCR signals mediated by Src family kinases are essential for the survival of naive T cells. J. Immunol. 169:2997-3005
47. Stefanova I, Dorfman JR, Germain RN. 2002. Self-recognition promotes the foreign antigen sensitivity of naive T lymphocytes. Nature 420:429-34
48. Zheng Y, Vig M, Lyons J, Van Parijs L, Beg AA. 2003. Combined deficiency of p50 and cRel in CD4+ T cells reveals an essential requirement for nuclear factor kappaB in regulating mature T cell survival and in vivo function. J. Exp. Med. 197:861-74
49. Hildeman DA, Mitchell T, Teague TK, Henson P, Day BJ, et al. 1999. Reactive oxygen species regulate activation-induced T cell apoptosis. Immunity 10:735-44
50. Bouillet P, Metcalf D, Huang DC, Tarlinton DM, Kay TW, et al. 1999. Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science 286:1735-38
51. Hildeman DA, Zhu Y, Mitchell TC, Bouillet P, Strasser A, et al. 2002. Activated T cell death in vivo mediated by proapoptotic bcl-2 family member bim. Immunity 16:759-67
52. Strasser A, Harris AW, Cory S. 1991. bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell 67:889-99
53. Mertsching E, Burdet C, Ceredig R. 1995. IL-7 transgenic mice: analysis of the role of IL-7 in the differentiation of thymocytes in vivo and in vitro. Int. Immunol. 7:401-14
54. Williams IR, Rawson EA, Manning L, Karaoli T, Rich BE, Kupper TS. 1997. IL-7 overexpression in transgenic mouse keratinocytes causes a lymphoproliferative skin disease dominated by intermediate TCR cells: evidence for a hierarchy in IL-7 responsiveness among cutaneous T cells. J. Immunol. 159:3044-56
55. Ingulli E, Mondino A, Khoruts A, Jenkins MK. 1997. In vivo detection of dendritic cell antigen presentation to CD4(+) T cells. J. Exp. Med. 185:2133-41
56. Miller MJ, Wei SH, Cahalan MD, Parker I. 2003. Autonomous T cell trafficking examined in vivo with intravital two-photon microscopy. Proc. Natl. Acad. Sci. USA 100:2604-9
57. Namen AE, Lupton S, Hjerrild K, Wignail J, Mochizuki DY, et al. 1988. Stimulation of B-cell progenitors by cloned murine interleukin-7. Nature 333:571-73
58. Hayashi S, Kunisada T, Ogawa M, Sudo T, Kodama H, et al. 1990. Stepwise progression of B lineage differentiation supported by interleukin 7 and other stromal cell molecules. J. Exp. Med. 171:1683-95
59. Tomana M, Ideyama S, Iwai K, Gyotoku J, Germeraad WT, et al. 1993. Involvement of IL-7 in the development of gamma delta T cells in the thymus. Thymus 21:141-57
60. Kitamura D, Roes J, Kuhn R, Rajewsky K. 1991. A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene. Nature 350:423-26
61. Lahn M, Kanehiro A, Takeda K, Terry J, Hahn YS, et al. 2002. MHC class I-dependent Vgamma4+ pulmonary T cells regulate alpha beta T cell-independent airway responsiveness. Proc. Natl. Acad. Sci. USA 99:8850-55
62. Shu HB, Johnson H. 2000. B cell maturation protein is a receptor for the tumor necrosis factor family member TALL-1. Proc. Natl Acad. Sci. USA 97:9156-61
63. Batten M, Groom J, Cachero TG, Qian F, Schneider P, et al. 2000. BAFF mediates survival of peripheral immature B lymphocytes. J. Exp. Med. 192:1453-66
64. Sharpe AH. 1995. Analysis of lymphocyte costimulation in vivo using transgenic and 'knockout' mice. Curr. Opin. Immunol. 7:389-95
65. Noel PJ, Boise LH, Green JM, Thompson CB. 1996. CD28 costimulation prevents cell death during primary T cell activation. J. Immunol. 157:636-42
66. Boise LH, Minn AJ, Noel PJ, June CH, Accavitti MA, et al. 1995. CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-XL. Immunity 3:87-98
67. Trauth BC, Klas C, Peters AM, Matzku S, Moller P, et al. 1989. Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 245:301-5
68. Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima S, et al. 1991. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66:233-43
69. Alderson MR, Tough TW, Davis-Smith T, Braddy S, Falk B, et al. 1995. Fas ligand mediates activation-induced cell death in human T lymphocytes. J. Exp. Med. 181:71-77
70. Mogil RJ, Radvanyi L, Gonzalez-Quintial R, Miller R, Mills G, et al. 1995. Fas (CD95) participates in peripheral T cell deletion and associated apoptosis in vivo. Int. Immunol. 7:1451-58
71. Lynch DH, Ramsdell F, Alderson MR. 1995. Fas and FasL in the homeostatic regulation of immune responses. Immunol. Today 16:569-74
72. Sytwu HK, Liblau RS, McDevitt HO. 1996. The roles of Fas/APO-1 (CD95) and TNF in antigen-induced programmed cell death in T cell receptor transgenic mice. Immunity 5:17-30
73. Miyawaki T, Uehara T, Nibu R, Tsuji T, Yachie A, et al. 1992. Differential expression of apoptosis-related Fas antigen on lymphocyte subpopulations in human peripheral blood. J. Immunol. 149:3753-58
74. Ryffel B, Mihatsch MJ. 1993. TNF receptor distribution in human tissues. Int. Rev. Exp. Pathol. 34(Pt. B):149-56
75. Cohen GM. 1997. Caspases: the executioners of apoptosis. Biochem. J. 326 (Pt. 1):1-16
76. Peter ME, Krammer PH. 1998. Mechanisms of CD95 (APO-1/Fas)-mediated apoptosis. Curr. Opin. Immunol. 10:545-51
77. Lenardo M, Chan KM, Hornung F, Mc-Farland H, Siegel R, et al. 1999. Mature T lymphocyte apoptosis-immune regulation in a dynamic and unpredictable antigenic environment. Annu. Rev. Immunol. 17:221-53
78. Kavurma MM, Khachigian LM. 2003. Signaling and transcriptional control of Fas ligand gene expression. Cell Death Differ. 10:36-44
79. Groghan TW, Davignon JL, Evans J, Allison JP, Eisenberg RA, et al. 1989. Diminished expression of the T cell receptor on the expanded lymphocyte population in MRL/Mp-lpr/lpr mice. Autoimmunity 2:97-111
80. Fisher GH, Rosenberg FJ, Straus SE, Dale JK, Middleton LA, et al. 1995. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81:935-46
81. Kakkanaiah VN, Pyle RH, Nagarkatti M, Nagarkatti PS. 1990. Evidence for major alterations in the thymocyte subpopulations in murine models of autoimmune diseases. J. Autoimmun. 3:271-88
82. Sainis K, Datta SK. 1988. CD4+ T cell lines with selective patterns of autoreactivity as well as CD4- CD8- T helper cell lines augment the production of idiotypes shared by pathogenic anti-DNA autoantibodies in the NZB x SWR model of lupus nephritis. J. Immunol. 140:2215-24
83. Singer PA, Theofilopoulos AN. 1990. Novel origin of lpr and gld cells and possible implications in autoimmunity. J. Autoimmun. 3:123-35
84. Herron LR, Eisenberg RA, Roper E, Kakkanaiah VN, Cohen PL, Kotzin BL. 1993. Selection of the T cell receptor repertoire in Lpr mice. J. Immunol. 151:3450-59
85. Giese T, Davidson WF. 1995. In CD8+ T cell-deficient lpr/lpr mice, CD4+ B220+ and CD4+B220- T cells replace B220+ double-negative T cells as the predominant populations in enlarged lymph nodes. J. Immunol. 154:4986-95
86. Pestano GA, Zhou Y, Trimble LA, Daley J, Weber GF, Cantor H. 1999. Inactivation of misselected CD8 T cells by CD8 gene methylation and cell death. Science 284:1187-91
87. Irmler M, Thome M, Hahne M, Schneider P, Hofmann K, et al. 1997. Inhibition of death receptor signals by cellular FLIP. Nature 388:190-95
88. Refaeli Y, Van Parijs L, London CA, Tschopp J, Abbas AK. 1998. Biochemical mechanisms of IL-2-regulated Fas-mediated T cell apoptosis. Immunity 8:615-23
89. Hildeman DA, Mitchell T, Kappler J, Marrack P. 2003. T cell apoptosis and reactive oxygen species. J. Clin. Invest. 111:575-81
90. Adams JM, Cory S. 1998. The Bcl-2 protein family: arbiters of cell survival. Science 281:1322-26
91. Opferman JT, Korsmeyer SJ. 2003. Apoptosis in the development and maintenance of the immune system. Nat. Immunol. 4:410-15
92. Lindsten T, Ross AJ, King A, Zong WX, Rathmell JC, et al. 2000. The combined functions of proapoptotic Bcl-2 family members bak and bax are essential for normal development of multiple tissues. Mol. Cell 6:1389-99
93. Wei MC, Zong WX, Cheng EH, Lindsten T, Panoutsakopoulou V, et al. 2001. Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 292:727-30
94. Strasser A, Puthalakath H, Bouillet P, Huang DC, O'Connor L, et al. 2000. The role of bim, a proapoptotic BH3-only member of the Bcl-2 family in cell-death control. Ann. NY Acad. Sci. 917:541-48
95. Zha J, Harada H, Yang E, Jockel J, Korsmeyer SJ. 1996. Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L). Cell 87:619-28
96. Datta SR, Dudek H, Tao X, Masters S, Fu H, et al. 1997. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91:231-41
97. Ishibashi Y, Nishimaki K, Asoh S, Nanbu-Wakao R, Yamada T, Ohta S. 1998. Pore formation domain of human pro-apoptotic Bax induces mammalian apoptosis as well as bacterial death without antagonizing anti-apoptotic factors. Biochem. Biophys. Res. Commun. 243:609-16
98. Nouraini S, Six E, Matsuyama S, Krajewski S, Reed JC. 2000. The putative pore-forming domain of Bax regulates mitochondrial localization and interaction with Bcl-X(L). Mol. Cell Biol. 20:1604-15
99. Brenner C, Cadiou H, Vieira HL, Zamzami N, Marzo I, et al. 2000. Bcl-2 and Bax regulate the channel activity of the mitochondrial adenine nucleotide translocator. Oncogene 19:329-36
100. Basanez G, Nechushtan A, Drozhinin O, Chanturiya A, Choe E, et al. 1999. Bax, but not Bcl-xL, decreases the lifetime of planar phospholipid bilayer membranes at subnanomolar concentrations. Proc. Natl. Acad. Sci. USA 96:5492-97
101. Tsujimoto Y, Shimizu S. 2002. The voltage-dependent anion channel: an essential player in apoptosis. Biochimie 84:187-93
102. Epand RF, Martinou JC, Montessuit S, Epand RM, Yip CM. 2002. Direct evidence for membrane pore formation by the apoptotic protein Bax. Biochem. Biophys. Res. Commun. 298:744-49
103. Kuwana T, Mackey MR, Perkins G, Ellisman MH, Latterich M, et al. 2002. Bid, Bax, and lipids cooperate to form supramolecular openings in the outer mitochondrial membrane. Cell 111:331-42
104. Kaipia A, Hsu SY, Hsueh AJ. 1997. Expression and function of a proapoptotic Bcl-2 family member Bcl-XL/Bcl-2-associated death promoter (BAD) in rat ovary. Endocrinology 138:5497-504
105. Davey GM, Kurts C, Miller JF, Bouillet P, Strasser A, et al. 2002. Peripheral deletion of autoreactive CD8 T cells by cross presentation of self-antigen occurs by a Bcl-2-inhibitable pathway mediated by Bim. J. Exp. Med. 196:947-55
106. Salmon M, Pilling D, Borthwick NJ, Viner N, Janossy G, et al. 1994. The progressive differentiation of primed T cells is associated with an increasing susceptibility to apoptosis. Eur. J. Immunol. 24:892-99
107. Mitchell T, Kappler J, Marrack P. 1999. Bystander virus infection prolongs activated T cell survival. J. Immunol. 162:4527-35
108. Grayson JM, Zajac AJ, Altman JD, Ahmed R. 2000. Cutting edge: increased expression of Bcl-2 in antigen-specific memory CD8+ T cells. J. Immunol. 164:3950-54
109. Puthalakath H, Huang DC, O'Reilly LA, King SM, Strasser A. 1999. The proapoptotic activity of the Bcl-2 family member Bim is regulated by interaction with the dynein motor complex. Mol. Cell 3:287-96
110. Liu X, Dai S, Zhu Y, Marrack P, Kappler JW. 2003. The structure of a Bcl-xL/Bim fragment complex: implications for Bim function. Immunity 19(3):341-52
111. Kearney ER, Pape KA, Loh DY, Jenkins MK. 1994. Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo. Immunity 1:327-39
112. Vella AT, McCormack JE, Linsley PS, Kappler JW, Marrack P. 1995. Lipopolysaccharide interferes with the induction of peripheral T cell death. Immunity 2:261-70
113. Croft M, Joseph SB, Miner KT. 1997. Partial activation of naive CD4 T cells and tolerance induction in response to peptide presented by resting B cells. J. Immunol. 159:3257-65
114. Sakata K, Sakata A, Kong L, Vela-Roch N, Talal N, Dang H. 1999. Monocyte rescue of human T cells from apoptosis is CD40/CD154 dependent. Scand J. Immunol. 50:479-84
115. Whitmire JK, Murali-Krishna K, Altman J, Ahmed R. 2000. Antiviral CD4 and CD8 T-cell memory: differences in the size of the response and activation requirements. Philos. Trans. R. Soc. Lond. Ser. B Biol. Sci. 355:373-79
116. Watts TH, DeBenedette MA. 1999. T cell co-stimulatory molecules other than CD28. Curr. Opin. Immunol. 11:286-93
117. Gramaglia I, Jember A, Pippig SD, Weinberg AD, Killeen N, Croft M. 2000. The OX40 costimulatory receptor determines the development of CD4 memory by regulating primary clonal expansion. J. Immunol. 165:3043-50
118. Maxwell JR, Weinberg A, Prell RA, Vella AT. 2000. Danger and OX40 receptor signaling synergize to enhance memory T cell survival by inhibiting peripheral deletion. J. Immunol. 164:107-12
119. Takahashi C, Mittler RS, Vella AT. 1999. Cutting edge: 4-1BB is a bona fide CD8 T cell survival signal. J. Immunol. 162:5037-40
120. Cannons JL, Lau P, Ghumman B, DeBenedette MA, Yagita H, et al. 2001. 4-1BB ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy. J. Immunol. 167:1313-24
121. Lee HW, Park SJ, Choi BK, Kim HH, Nam KO, Kwon BS. 2002. 4-1BB promotes the survival of CD8+ T lymphocytes by increasing expression of Bcl-xL and Bfl-1. J. Immunol. 169:4882-88
122. Gravestein LA, Amsen D, Boes M, Calvo CR, Kruisbeek AM, Borst J. 1998. The TNF receptor family member CD27 signals to Jun N-terminal kinase via Traf-2. Eur. J. Immunol. 28:2208-16
123. Arch RH, Thompson CB. 1998. 4-1BB and Ox40 are members of a tumor necrosis factor (TNF)-nerve growth factor receptor subfamily that bind TNF receptor-associated factors and activate nuclear factor kappaB. Mol. Cell Biol. 18:558-65
124. Kawamata S, Hori T, Imura A, Takaori-Kondo A, Uchiyama T. 1998. Activation of OX40 signal transduction pathways leads to tumor necrosis factor receptor-associated factor (TRAF) 2- and TRAF5-mediated NF-kappaB activation. J. Biol. Chem. 273:5808-14
125. Akiba H, Nakano H, Nishinaka S, Shindo M, Kobata T, et al. 1998. CD27, a member of the tumor necrosis factor receptor superfamily, activates NF-kappaB and stress-activated protein kinase/c-Jun N-terminal kinase via TRAF2, TRAF5, and NF-kappaB-inducing kinase. J. Biol. Chem. 273:13353-58
126. Speiser DE, Lee SY, Wong B, Arron J, Santana A, et al. 1997. A regulatory role for TRAF1 in antigen-induced apoptosis of T cells. J. Exp. Med. 185:1777-83
127. Mitchell TC, Hildeman D, Kedl RM, Teague TK, Schaefer BC, et al. 2001. Immunological adjuvants promote activated T cell survival via induction of Bcl-3. Nat. Immunol. 2:397-402
128. Ohno H, Takimoto G, McKeithan TW. 1990. The candidate proto-oncogene bcl-3 is related to genes implicated in cell lineage determination and cell cycle control. Cell 60:991-97
129. Bours V, Villalobos J, Burd PR, Kelly K, Siebenlist U. 1990. Cloning of a mitogen-inducible gene encoding a kappa B DNA-binding protein with homology to the rel oncogene and to cell-cycle motifs. Nature 348:76-80
130. Kerr LD, Duckett CS, Wamsley P, Zhang Q, Chiao P, et al. 1992. The protooncogene bcl-3 encodes an I kappa B protein. Genes Dev. 6:2352-63
131. Fujita T, Nolan GP, Liou HC, Scott ML, Baltimore D. 1993. The candidate protooncogene bcl-3 encodes a transcriptional coactivator that activates through NF-kappa B p50 homodimers. Genes Dev. 7:1354-63
132. Viatour P, Bentires-Alj M, Chariot A, Deregowski V, de Leval L, et al. 2003. NF-kappa B2/p100 induces Bcl-2 expression. Leukemia 17:1349-56
133. Cheng EH, Sheiko TV, Fisher JK, Craigen WJ, Korsmeyer SJ. 2003. VDAC2 inhibits BAK activation and mitochondrial apoptosis. Science 301:513-17
134. Tough DF, Sprent J. 1994. Turnover of naive- and memory-phenotype T cells. J. Exp. Med. 179:1127-35
135. Tough DF, Borrow P, Sprent J. 1996. Induction of bystander T cell proliferation by viruses and type I interferon in vivo. Science 272:1947-50
136. Zhang X, Sun S, Hwang I, Tough DF, Sprent J. 1998. Potent and selective stimulation of memory-phenotype CD8+ T cells in vivo by IL-15. Immunity 8:591-99
137. Murali-Krishna K, Lau LL, Sambhara S, Lemonnier F, Altman J, Ahmed R. 1999. Persistence of memory CD8 T cells in MHC class I-deficient mice. Science 286:1377-81
138. Ku CC, Murakami M, Sakamoto A, Kappler J, Marrack P. 2000. Control of homeostasis of CD8+ memory T cells by opposing cytokines. Science 288:675-88
139. Becker TC, Wherry EJ, Boone D, Murali-Krishna K, Antia R, et al. 2002. Interleukin 15 is required for proliferative renewal of virus-specific memory CD8 T cells. J. Exp. Med. 195:1541-48
140. Goldrath AW, Sivakumar PV, Glaccum M, Kennedy MK, Bevan MJ, et al. 2002. Cytokine requirements for acute and Basal homeostatic proliferation of naive and memory CD8+ T cells. J. Exp. Med. 195:1515-22
141. Tan JT, Ernst B, Kieper WC, LeRoy E, Sprent J, Surh CD. 2002. Interleukin (IL)-15 and IL-7 jointly regulate homeostatic proliferation of memory phenotype CD8+ cells but are not required for memory phenotype CD4+ cells. J. Exp. Med. 195:1523-32
142. Grabstein KH, Eisenman J, Shanebeck K, Rauch C, Srinivasan S, et al. 1994. Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor. Science 264:965-68
143. Waldmann T, Tagaya Y, Bamford R. 1998. Interleukin-2, interleukin-15, and their receptors. Int. Rev. Immunol. 16:205-26
144. Liew FY. 2003. The role of innate cytokines in inflammatory response. Immunol. Lett. 85:131-34
145. Dubois S, Mariner J, Waldmann TA, Tagaya Y. 2002. IL-15Ralpha recycles and presents IL-15 in trans to neighboring cells. Immunity 17:537-47
146. Kennedy MK, Glaccum M, Brown SN, Butz EA, Viney JL, et al. 2000. Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. J. Exp. Med. 191:771-80
147. Lodolce JP, Boone DL, Chai S, Swain RE, Dassopoulos T, et al. 1998. IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation. Immunity 9:669-76
148. Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A. 1999. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401:708-12
149. Manjunath N, Shankar P, Wan J, Weninger W, Crowley MA, et al. 2001. Effector differentiation is not prerequisite for generation of memory cytotoxic T lymphocytes. J. Clin. Invest. 108:871-78
150. Seddon B, Tomlinson P, Zamoyska R. 2003. Interleukin 7 and T cell receptor signals regulate homeostasis of CD4 memory cells. Nat. Immunol. 4:680-86
151. de Souza AR, Swanson B, Robertson J, Bender J, Kappler J, Marrack P. 2002. Some properties of T cells in animals. Adv. Exp. Med. Biol. 512:121-28
152. Swain SL. 2000. CD4 T-cell memory can persist in the absence of class II. Philos. Trans. R Soc. Lond. Ser. B Biol. Sci. 355:407-11
153. Swain SL, Agrewala JN, Brown DM, Roman E. 2002. Regulation of memory CD4 T cells: generation, localization and persistence. Adv. Exp. Med. Biol. 512:113-20
154. Selin LK, Lin MY, Kraemer KA, Pardoll DM, Schneck JP, et al. 1999. Attrition of T cell memory: selective loss of LCMV epitope-specific memory CD8 T cells following infections with heterologous viruses. Immunity 11:733-42
155. Marrack P, Kappler J, Mitchell T. 1999. Type I interferons keep activated T cells alive. J. Exp. Med. 189:521-30
156. McNally JM, Zarozinski CC, Lin MY, Brehm MA, Chen HD, Welsh RM. 2001. Attrition of bystander CD8 T cells during virus-induced T-cell and interferon responses. J. Virol. 75:5965-76
157. Kaech SM, Hemby S, Kersh E, Ahmed R. 2002. Molecular and functional profiling of memory CD8 T cell differentiation. Cell 111:837-51